Psychiatric Drugs: New Developments and Market Analysis by Drug Class and Clinical Indication - Market Research Reports

Welcome - Home - Register - Login - Help/FAQ - 0 items

Search
Enter keywords, a title or
a report id number below.

Advanced


	Select a currency for use throughout the site

Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying

| More

Electronic
Site License
Enterprisewide

Psychiatric Drugs: New Developments and Market Analysis by Drug Class and Clinical Indication
Drug and Market Development Publishing, Nov 2004, Pages: 250



		Description



		Table of Contents



		Summary



		Enquire before Buying


	Send to a Friend

Send to a Friend

To email a friend details of Psychiatric Drugs: New Developments and Market Analysis by Drug Class and Clinical Indication complete the form below and click on "Send".

* Required Information

Your Friend's Details

Friend's Full Name *

Friend's Email Address *

A message for your Friend

Your Contact Details

Your Name *

Email Address *

Customers who bought this item also bought

Anxiety Disorders - Viable Indication for Antipsychotics Companies

Pharmacogenomics for Clinical Use and in Drug Development

Lifestyle Drugs Market Outlook: Key Indications, Epidemiology, and Emergent Drugs

Emerging Diagnostic Technologies for Use in Psychiatric Indications

Pain Therapeutics - Drugs, Markets and Companies

Anxiety Disorders - A Decade of Declining Revenues

Infectious Diseases Drugs Markets

Are There Changes Ahead for the Generalized Anxiety Disorder Market?

Neuroprotection - Drugs, Markets and Companies

Angiotensin as a target for the treatment of Alzheimer's disease, anxiety and depression

Handbook of Psychiatric Drugs

Drugs in the Pipeline--An R&D Analysis

Top of page